SCHEMBL29547500

SCHEMBL29547500

O=c1c2ccc(N3CCCNCC3)cc2oc2c(F)cccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR6 P50406 5/20 0.40
▸ HTR3A P46098 4/20 0.39
▸ HTR1A P08908 3/20 0.39
▸ HTR7 P34969 3/20 0.39
▸ HTR3E A5X5Y0 3/20 0.39
▸ HTR3B O95264 3/20 0.39
▸ HTR3D Q70Z44 3/20 0.39
▸ HTR3C Q8WXA8 3/20 0.39
▸ SIGMAR1 Q99720 3/20 0.39
▸ HTR2C P28335 2/20 0.39
▸ HTR2A P28223 2/20 0.39
▸ HTR2B P41595 2/20 0.39
▸ ADRB1 P08588 2/20 0.39
▸ TP53 P04637 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ THRB P10828 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ SLC6A4 P31645 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19642697 1.00 HTR6 (0.40) HTR6HTR3AHTR1AHTR7HTR3E
SCHEMBL19642323 0.90 MAOA (0.43) HTR6HTR1AHTR7MAOAALDH1A1
SCHEMBL19662320 0.89 MAOA (0.39) HTR6HTR3AHTR1AHTR7HTR3E
SCHEMBL29547740 0.89 MAOA (0.42) HTR6HTR1AHTR7MAOAALDH1A1
SCHEMBL19662132 0.89 MAOA (0.42) HTR6HTR1AHTR7MAOAALDH1A1
SCHEMBL19642268 0.89 MAOA (0.42) HTR6HTR1AHTR7MAOAALDH1A1
SCHEMBL19642388 0.83 CYP1A1 (0.43) CYP1A2MAOAALDH1A1
SCHEMBL19642400 0.82 HTR6 (0.49) HTR6HTR1AHTR7CYP1A2HRH4
SCHEMBL19642402 0.80 TTR (0.39) TP53CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL29547484 0.80 USP2 (0.38) HTR6HTR1AHTR7TP53CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109311860-B Xanthone derivatives for the treatment or prevention of hepatitis B virus diseases 豪夫迈·罗氏有限公司 2022-04-08 — — CN claimed
CN-109311860-B Xanthone derivatives for the treatment or prevention of hepatitis B virus diseases 豪夫迈·罗氏有限公司 2022-04-08 — — CN disclosed
Send feedback